instruction stringlengths 732 1.39k | output stringlengths 651 861 |
|---|---|
SUBJECT: Multi-product safety and information request for Product A and Product B
BODY:
To Whom It May Concern,
I am the prescribing advisor for a mental health trust where Product A is used for bipolar disorder and Product B for sleep disturbances. and I am formally reporting two matters. The first is a safety issue ... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "93%"}, "Analysis": "The email reports adverse symptoms where the patient documented dyspnea and chest tightness within 30 minutes of ingestion temporally associated with Product A initiation, with clinical int... |
SUBJECT: Comprehensive inquiry on Product A and supply inquiry
BODY:
Dear Compliance Team,
I am the lead clinical pharmacist at a regional oncology unit and I am contacting you regarding two separate topics. The first is a safety report for Product A where The patient is a 32 year old female with antiphospholipid synd... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the patient developed deep-vein thrombosis in the left calf within 2 weeks temporally associated with Product A initiation, with clinical intervention taken, qu... |
SUBJECT: Request for details about Product A and supply inquiry
BODY:
Dear Medical and Commercial Teams,
I am the lead clinical coordinator for a hospice network and I wish to bring two matters to your attention. The first is an adverse reaction report concerning Product A where The patient is a 42 year old female wit... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports adverse symptoms where the patient suffered from persistent headaches that increased in intensity over 5 days temporally associated with Product A initiation, with clinical interventi... |
SUBJECT: Pricing inquiry and safety signal for Product A and Product B
BODY:
Dear Clinical Coordinator,
I am the healthcare administrator at Premier Medical Group overseeing the concurrent use of Product A in infusion centres and Product B in outpatient pharmacies. and I am writing to report two separate issues. The f... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient suffered from insomnia that progressed to near-total sleep deprivation over 1 week temporally associated with Product A initiation, with... |
SUBJECT: Complex issue involving Product A and institutional inquiry
BODY:
Dear Clinical and Supply Chain Team,
I am the lead clinical coordinator for a hospice network and I am contacting you regarding two separate topics. The first concerns clinical guidance on Product A where Please provide the immunogenicity risk ... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Please provide the immunogenicity risk asses... |
SUBJECT: Issue reported with Product A and Product B
BODY:
Dear Adverse Event Reporting Center,
Our outpatient clinic manages a cohort of patients on Product A for anticoagulation and Product B for pain management after orthopaedic surgery. and I am writing to report two separate issues. The first involves Product A w... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the patient reported severe muscle pain with elevated creatine kinase levels on day 9 temporally associated with Product A initiation, with clinical... |
SUBJECT: Co-therapy observation and commercial query on Product A and Product B
BODY:
Dear Drug Safety Department,
As the institutional buyer for City Hospital Network, I am responsible for inventory planning that includes Product A for emergency resuscitation and Product B for chronic disease management. and I am wri... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "96%"}, "Analysis": "The email reports adverse symptoms where the patient developed severe photosensitivity with blistering after 14 days of continuous use temporally associated with Product A initiation, with ... |
SUBJECT: Complex issue involving Product A and Product B
BODY:
Dear Medical Director,
Our integrated care system manages patients discharged on Product A for heart failure and Product B for chronic pain across 15 community clinics. and I am contacting you about two separate matters. The first is a request for clinical... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What is the bioequivalence data for... |
SUBJECT: Safety and quality note on Product A and institutional inquiry
BODY:
Dear Clinical Coordinator,
I am the clinical pharmacist for a long-term care facility and I am contacting you regarding two separate topics. The first problems clinical guidance on Product A where Is there any real-world evidence on the long... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there any real-world evidence on the long... |
SUBJECT: Integrated feedback regarding Product A and Product B
BODY:
Dear Adverse Event Reporting Center,
As the pharmacy director of a 500-bed tertiary hospital, I am coordinating formulary reviews for Product A in cardiology and Product B in neurology. and I am writing to raise two distinct concerns. The first is a ... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you share the patient-reported o... |
SUBJECT: Clarification sought on Product A and Product B
BODY:
Dear Healthcare Liaison,
I am the pharmacy and therapeutics committee chair at a regional medical centre evaluating co-administration protocols for Product A and Product B in high-risk populations. I have two separate matters to raise. Firstly regarding Pr... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you share the patient-reported o... |
SUBJECT: Observation during use of Product A and institutional contract enquiry
BODY:
Dear Clinical Affairs,
I am writing as the clinical coordinator for a multi-site renal network and I am writing to formally report two issues. The first is a product complaint regarding Product A where our inspection revealed that th... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports a product quality defect in Product A where the refill cartridge for the inhaler device failed to lock into place and fell out upon inversion in a specific identified batch with q... |
SUBJECT: Pricing inquiry and safety signal for Product A and Product B
BODY:
Dear Pharmacovigilance and Quality Officer,
I am writing as the clinical coordinator for a multi-site renal network where Product A is used for anaemia management and Product B for phosphate binding. and I am writing to report two separate is... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "91%"}, "Analysis": "The email reports adverse symptoms where the patient developed acute pancreatitis with epigastric pain and elevated lipase after 7 days temporally associated with Product A initiation, with... |
SUBJECT: Distribution and side-effect profile of Product A and Product B
BODY:
Dear Adverse Event Reporting Center,
I am the healthcare administrator at Premier Medical Group overseeing the concurrent use of Product A in infusion centres and Product B in outpatient pharmacies. and I wish to raise two issues simultaneo... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient observed blood in urine after 4 days of administration temporally associated with Product A initiation, with clinical intervention and i... |
SUBJECT: Inquiry and feedback about Product A and Product B
BODY:
Dear Pharmacovigilance Team,
Our urgent care centre frequently dispenses Product A for acute migraine and Product B for nausea management in the same patient episodes. and I am writing to report two separate issues. The first involves Product A where Th... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the patient developed severe photosensitivity with blistering after 14 days of continuous use temporally associated with Product A initiation, with ... |
SUBJECT: Labeling error and clinical query about Product A and supply inquiry
BODY:
Dear Adverse Event Reporting Center,
I am the ward manager on a busy medical unit and I am writing to raise two separate matters. The first is an adverse event involving Product A. The patient is a 52 year old male with hepatitis C. He... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient had uncontrolled tremors in both hands beginning the second day temporally associated with Product A initiation, with clinical intervention taken, q... |
SUBJECT: Issue reported with Product A and institutional inquiry
BODY:
Dear Regulatory Affairs,
I am the medical director of a residential care home group managing over 400 elderly residents and I have two distinct issues to address. Regarding Product A for formulary evaluation, Is Product A approved for pediatric use... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is Product A approved for pediatric use, and... |
SUBJECT: Market access and subject impact of Product A and institutional inquiry
BODY:
Dear Product Team,
I am the lead clinical coordinator for a hospice network and I am writing to formally request information on two fronts. The first is clinical information regarding Product A where Please provide the recommended s... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Please provide the recommended storage tempe... |
SUBJECT: Market access and patient impact of Product A and Product B
BODY:
Dear Customer Support,
I am the clinical pharmacy specialist in a busy emergency department where Product A is used for rapid anticoagulation reversal and Product B for gastric acid suppression. and I wish to raise two issues. The first concern... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Are there any contraindications for... |
SUBJECT: Dual product inquiry and report about Product A and Product B
BODY:
Dear Pharmacovigilance and Quality Officer,
Our supply chain team coordinates direct-to-ward deliveries of Product A for stroke units and Product B for orthopaedic wards across the National Health Trust. and I need to address two separate iss... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you share the patient-reported o... |
SUBJECT: Joint product evaluation and safety report for Product A and Product B
BODY:
Dear Medical Information Team,
As the institutional buyer for City Hospital Network, I am responsible for inventory planning that includes Product A for emergency resuscitation and Product B for chronic disease management. and I need... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Does Product A have any known intera... |
SUBJECT: Complex issue involving Product A and Product B
BODY:
Dear Pharmacovigilance Team,
I am the prescribing advisor for a mental health trust where Product A is used for bipolar disorder and Product B for sleep disturbances. and I need to address two separate issues. Regarding Product A our clinical team requires... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you provide guidance on dose t... |
SUBJECT: Combined quality and clinical report for Product A and Product B
BODY:
Dear Clinical Lead Pharmacist,
I am the market access manager evaluating regional coverage for Product A in dermatology and Product B in rheumatology outpatient services. I have two separate concerns to raise. The first is a clinical infor... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Please provide the recommended stor... |
SUBJECT: Multi-product safety and information request for Product A and Product B
BODY:
Dear Adverse Event Reporting Center,
I am the lead clinical coordinator for a hospice network where Product A is used for chronic pain and Product B for breakthrough symptom control. and I need to address two separate issues. Regar... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you clarify whether Product A is... |
SUBJECT: Urgent concern regarding Product A and institutional contract enquiry
BODY:
Dear Healthcare Liaison,
I am the head of formulary and medicines optimisation for an integrated care board and I wish to bring two matters to your attention. The first is a quality assurance concern with Product A 20mg where the adhe... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports a product quality defect in Product A where the adhesive on the secondary label failed, causing it to detach from the primary container surface in a specific identified batch with... |
SUBJECT: Urgent concern regarding Product A and institutional inquiry
BODY:
Dear Pharmacovigilance and Quality Officer,
As the head of pharmacy procurement for a regional health trust and I am contacting you regarding two separate topics. The first concerns clinical guidance on Product A where What is the established ... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the established dosing interval for ... |
SUBJECT: Unexpected reaction linked to Product A and Product B
BODY:
Dear Medical Director,
I am the prescribing advisor for a mental health trust where Product A is used for bipolar disorder and Product B for sleep disturbances. and I am writing to formally report two distinct matters. Regarding Product A I need to c... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Can you share the patient-reported ... |
SUBJECT: Urgent concern regarding Product A and Product B
BODY:
Dear Medical Affairs,
I am the healthcare administrator at Premier Medical Group overseeing the concurrent use of Product A in infusion centres and Product B in outpatient pharmacies. and I am formally reporting two concerns. The first is a safety issue w... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient developed a widespread erythematous rash within 48 hours of the first dose temporally associated with Product A initiation, with clinica... |
SUBJECT: Inquiry and feedback about Product A and Product B
BODY:
Dear Drug Safety and Medical Information,
I am the healthcare administrator at Premier Medical Group overseeing the concurrent use of Product A in infusion centres and Product B in outpatient pharmacies. and I am contacting you about two separate matter... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Could you send any recent peer-revi... |
SUBJECT: Request for details about Product A and Product B
BODY:
To Whom It May Concern,
As the medical liaison for Northshore Physicians Group, I coordinate care transitions involving Product A for respiratory conditions and Product B for cardiovascular protection. and I am contacting you about two separate matters. ... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Can you provide a summary of clinic... |
SUBJECT: Co-therapy observation and commercial query on Product A and institutional inquiry
BODY:
Dear Medical Information and Safety Team,
I am the clinical pharmacist for a long-term care facility and I wish to bring two matters to your attention. The first is a medical information request about Product A specifical... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Are there any dietary restrictions or food i... |
SUBJECT: Supply and experience review of Product A and institutional contract enquiry
BODY:
Dear Safety Team,
I am the clinical pharmacy specialist in a busy emergency department and I am contacting you regarding two separate topics. The first is a product defect report for Product A where a tablet was observed to be ... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports a product quality defect in Product A where a tablet was observed to be split into 2 unequal fragments inside an intact blister cavity in a specific identified batch with quaranti... |
SUBJECT: Dual product inquiry and report about Product A and Product B
BODY:
To Whom It May Concern,
I am the ward manager on a busy medical unit where several inpatients are currently receiving Product A for infection prophylaxis alongside Product B for gastric protection. and I am contacting you about two separate m... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Does Product A require renal functi... |
SUBJECT: Multi-faceted concern about Product A and Product B
BODY:
To Whom It May Concern,
I am writing as the clinical pharmacist for a long-term care facility where residents receive Product A for chronic heart failure and Product B for osteoporosis prevention. and I am contacting you about two separate matters. The... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Please provide the immunogenicity r... |
SUBJECT: Dual product inquiry and report about Product A and institutional contract enquiry
BODY:
Dear Quality Assurance and Commercial Teams,
As the formulary coordinator for a 300-bed community hospital and I am contacting you regarding two separate topics. The first is a product defect report for Product A where th... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports a product quality defect in Product A where the adhesive on the secondary label failed, causing it to detach from the primary container surface in a specific identified batch with... |
SUBJECT: Supply and experience review of Product A and Product B
BODY:
Dear Pharmacy Director,
Our outpatient clinic manages a cohort of patients on Product A for anticoagulation and Product B for pain management after orthopaedic surgery. I have two separate matters to raise. The first is a clinical information reque... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What is the recommended starting do... |
SUBJECT: Follow-up needed for Product A and institutional contract enquiry
BODY:
Dear Adverse Event Reporting Center,
I am the lead clinical pharmacist at a regional oncology unit and I am contacting you regarding two separate topics. The first is a product defect report for Product A where the ampoule neck shattered ... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "95%"}, "Analysis": "The email reports a product quality defect in Product A where the ampoule neck shattered during attempted opening despite following the recommended technique in a specific identified batch with qua... |
SUBJECT: Joint product evaluation and safety report for Product A and Product B
BODY:
Dear Pharmacovigilance and Quality Officer,
Our supply chain team coordinates direct-to-ward deliveries of Product A for stroke units and Product B for orthopaedic wards across the National Health Trust. and I am writing to formally ... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Is Product A approved for pediatric... |
SUBJECT: Safety and quality note on Product A and institutional inquiry
BODY:
Dear Drug Safety and Medical Information,
As the pharmacy director of a 500-bed tertiary hospital and I wish to bring two matters to your attention. The first is a medical information request about Product A specifically Is there a black box... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there a black box warning or regulatory s... |
SUBJECT: Follow-up needed for Product A and institutional contract enquiry
BODY:
Dear Integrated Quality and Safety Team,
I am the quality officer at a private hospital and I am writing to formally report two issues. The first is a product complaint regarding Product A where our inspection revealed that a vial arrived... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "92%"}, "Analysis": "The email reports a product quality defect in Product A where a vial arrived with a cracked neck, causing leakage of approximately 2 ml of solution in a specific identified batch with quarantined s... |
SUBJECT: Observation during use of Product A and institutional contract enquiry
BODY:
Dear Quality Officer,
I am the clinical pharmacist for a long-term care facility and I wish to bring two matters to your attention. The first is a quality assurance concern with Product A 50mg where the barcode on the outer packaging... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports a product quality defect in Product A where the barcode on the outer packaging failed to scan at three separate pharmacy workstations in a specific identified batch with quarantin... |
SUBJECT: Integrated feedback regarding Product A and Product B
BODY:
Dear Healthcare Liaison,
I am the pharmacy and therapeutics committee chair at a regional medical centre evaluating co-administration protocols for Product A and Product B in high-risk populations. I have two distinct concerns to raise. The first is ... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the patient developed deep-vein thrombosis in the left calf within 2 weeks temporally associated with Product A initiation, with clinical interventi... |
SUBJECT: Comprehensive inquiry on Product A and institutional inquiry
BODY:
Dear Medical Information and Safety Team,
I am the medical director of a specialist cardiovascular centre and I am contacting you regarding two separate topics. The first problems clinical guidance on Product A where What monitoring parameters... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What monitoring parameters are recommended d... |
SUBJECT: Follow-up needed for Product A and institutional inquiry
BODY:
Dear Compliance Team,
I am the ward manager on a busy medical unit and I wish to bring two matters to your attention. The first is a medical information request about Product A specifically Can you share data on the bioavailability of Product A un... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you share data on the bioavailability of... |
SUBJECT: Packaging defect and dosing question for Product A and institutional inquiry
BODY:
Dear Safety Team,
As the pharmacy director of a 500-bed tertiary hospital and I am writing to formally request information on two fronts. The first is clinical information regarding Product A where Could you send any recent pee... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you send any recent peer-reviewed publ... |
SUBJECT: Joint product evaluation and safety report for Product A and Product B
BODY:
Dear Pharmacovigilance and Quality Officer,
I am the chief of medicine at a downtown clinic where Product A is prescribed for autoimmune conditions and Product B for metabolic syndrome management. and I am writing to report two separ... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "94%"}, "Analysis": "The email reports adverse symptoms where the patient noted visual disturbances including blurred vision and photophobia after 3 doses temporally associated with Product A initiation, with c... |
SUBJECT: Dual product inquiry and report about Product A and supply inquiry
BODY:
Dear Clinical and Supply Chain Team,
I am the director of pharmacy for a network of community hospitals and I am writing to formally report two issues. The first is a individual safety concern with Product A where The patient is a 26 yea... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient developed Stevens-Johnson syndrome-like lesions across torso and arms temporally associated with Product A initiation, with clinical intervention ta... |
SUBJECT: Patient feedback concerning Product A and institutional inquiry
BODY:
Dear Clinical and Supply Chain Team,
I am the medical director of a residential care home group managing over 400 elderly residents and I have two distinct issues to address. Regarding Product A for formulary evaluation, What is the mechani... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the mechanism of action for Product ... |
SUBJECT: Comprehensive inquiry on Product A and institutional inquiry
BODY:
Dear Product Team,
I am the clinical pharmacist for a long-term care facility and I have two distinct issues to address. Regarding Product A for formulary evaluation, What is the bioequivalence data for the generic formulation of Product A com... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the bioequivalence data for the gene... |
SUBJECT: Safety and quality note on Product A and Product B
BODY:
Dear Quality and Commercial Teams,
Our hospital pharmacist network reviews dual-product regimens including Product A for infectious disease and Product B for prophylactic gastroprotection. and I am writing to report two separate issues. The first involv... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient developed acute pancreatitis with epigastric pain and elevated lipase after 7 days temporally associated with Product A initiation, with... |
SUBJECT: Complex issue involving Product A and Product B
BODY:
Dear Regulatory Affairs,
I am writing as the clinical pharmacist for a long-term care facility where residents receive Product A for chronic heart failure and Product B for osteoporosis prevention. I have two distinct concerns to raise. The first is an adv... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the subject developed new-onset atrial fibrillation within 72 hours temporally associated with Product A initiation, with clinical intervention and ... |
SUBJECT: Safety and quality note on Product A and supply inquiry
BODY:
Dear Quality Officer,
I am the clinical pharmacy specialist in a busy emergency department and I am contacting you regarding two separate topics. The first is a safety report for Product A where The individual is a 58 year old male with COPD. He co... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "96%"}, "Analysis": "The email reports adverse symptoms where the patient reported dizziness and orthostatic hypotension after 2 doses temporally associated with Product A initiation, with clinical intervention taken, qual... |
SUBJECT: Unexpected reaction linked to Product A and supply inquiry
BODY:
Dear Customer Support,
I am the quality officer at a private hospital and I am writing to formally report two issues. The first is a patient safety concern with Product A where The patient is a 55 year old female with a history of migraine. She ... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports adverse symptoms where the individual developed a widespread erythematous rash within 48 hours of the first dose temporally associated with Product A initiation, with clinical interve... |
SUBJECT: Pricing inquiry and safety signal for Product A and supply inquiry
BODY:
Dear Quality and Commercial Teams,
I am the lead clinical coordinator for a hospice network and I have two distinct issues to address. The first concerns Product A where The patient is a 26 year old female with epilepsy. She developed a ... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "96%"}, "Analysis": "The email reports adverse symptoms where the patient developed a widespread erythematous rash within 48 hours of the first dose temporally associated with Product A initiation, with clinical interventi... |
SUBJECT: Market access and patient impact of Product A and supply inquiry
BODY:
Dear Regulatory Affairs,
As the head of pharmacy procurement for a regional health trust and I wish to bring two matters to your attention. The first is an adverse reaction report concerning Product A where The patient is a 41 year old fem... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "93%"}, "Analysis": "The email reports adverse symptoms where the patient noticed dark tarry stools indicating possible gastrointestinal bleeding after 8 days temporally associated with Product A initiation, with clinical ... |
SUBJECT: Clinical observation with Product A and supply inquiry
BODY:
Dear Integrated Quality and Safety Team,
I am the chief pharmacist at a district general hospital and I am contacting you regarding two separate topics. The first is a safety report for Product A where The patient is a 45 year old male with no known... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "93%"}, "Analysis": "The email reports adverse symptoms where the patient noted blood in urine after 4 days of administration temporally associated with Product A initiation, with clinical intervention taken, qualifying as... |
SUBJECT: Market access and patient impact of Product A and Product B
BODY:
Dear Medical Director,
I am the clinical lead pharmacist at a large teaching hospital where Product A is used in the oncology unit and Product B is used in the endocrinology service. and I am formally reporting two concerns. The first is a safe... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient complained of severe abdominal cramping and diarrhea for 3 consecutive days temporally associated with Product A initiation, with clinic... |
SUBJECT: Packaging defect and dosing question for Product A and Product B
BODY:
Dear Medical Director,
I am the lead clinical coordinator for a hospice network where Product A is used for chronic pain and Product B for breakthrough symptom control. and I wish to raise two issues simultaneously. The first is an adverse... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "96%"}, "Analysis": "The email reports adverse symptoms where the patient reported severe muscle pain with elevated creatine kinase levels on day 9 temporally associated with Product A initiation, with clinical... |
SUBJECT: Labeling error and clinical query about Product A and Product B
BODY:
Dear Adverse Event Reporting Center,
I am the business development lead at MedCore Partners exploring joint procurement initiatives for Product A in nephrology and Product B in hepatology. and I need to address two issues simultaneously. Th... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Are there any dietary restrictions ... |
SUBJECT: Clarification sought on Product A and Product B
BODY:
Dear Medical Affairs,
I am the chief of medicine at a downtown clinic where Product A is prescribed for autoimmune conditions and Product B for metabolic syndrome management. and I wish to raise two issues. The first concerns medical information about Prod... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Is there any guidance on Product A ... |
SUBJECT: Patient feedback concerning Product A and Product B
BODY:
Dear Healthcare Liaison,
I am the healthcare administrator at Premier Medical Group overseeing the concurrent use of Product A in infusion centres and Product B in outpatient pharmacies. I have two distinct concerns to raise. The first is an adverse re... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the patient had uncontrolled tremors in both hands beginning the second day temporally associated with Product A initiation, with clinical intervent... |
SUBJECT: Labeling error and clinical query about Product A and Product B
BODY:
Dear Clinical Coordinator,
As the head of pharmacy procurement for a regional health trust, I am responsible for supply agreements covering Product A in haematology and Product B in gastroenterology. and I need to address two issues simulta... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Is there any real-world evidence on... |
SUBJECT: Market access and patient impact of Product A and Product B
BODY:
Dear Quality and Commercial Teams,
I am writing as the clinical coordinator for a multi-site renal network where Product A is used for anaemia management and Product B for phosphate binding. and I wish to raise two issues simultaneously. The fi... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "93%"}, "Analysis": "The email reports adverse symptoms where the patient experienced profound fatigue and muscle weakness after 6 days of treatment temporally associated with Product A initiation, with clinica... |
SUBJECT: Joint product evaluation and safety report for Product A and institutional contract enquiry
BODY:
Dear Quality Assurance and Commercial Teams,
I am the nurse practitioner in a busy GP practice and I am writing to formally report two issues. The first is a product complaint regarding Product A where our inspec... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "96%"}, "Analysis": "The email reports a product quality defect in Product A where the oral syringe provided in the kit had illegible graduation markings making accurate dosing impossible in a specific identified batch... |
SUBJECT: Market access and patient impact of Product A and institutional inquiry
BODY:
Dear Patient Support,
I am the chief pharmacist at a district general hospital and I am contacting you regarding two separate topics. The first concerns clinical guidance on Product A where Can you provide the pharmacokinetic profil... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you provide the pharmacokinetic profile ... |
SUBJECT: Dual product inquiry and report about Product A and institutional inquiry
BODY:
Dear Adverse Event Reporting Center,
I am the ward manager on a busy medical unit and I am writing to raise two separate matters. The first is a clinical information request regarding Product A which our medical advisory committee... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Does Product A require premedication with an... |
SUBJECT: Supply and experience review of Product A and supply inquiry
BODY:
Dear Clinical Lead Pharmacist,
I am the lead clinical pharmacist at a regional oncology unit and I have two distinct issues to address. The first concerns Product A where The patient is a 57 year old male with sleep apnea and obesity. He devel... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports adverse symptoms where the patient developed angioedema of the lips and tongue within 90 minutes of ingestion temporally associated with Product A initiation, with clinical interventi... |
SUBJECT: Comprehensive inquiry on Product A and institutional contract enquiry
BODY:
Dear Patient Safety and Market Access Team,
I am the pharmacy and therapeutics committee chair at a regional medical centre and I wish to bring two matters to your attention. The first is a quality assurance concern with Product A 25m... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "95%"}, "Analysis": "The email reports a product quality defect in Product A where the accompanying patient leaflet was missing entirely from 2 of the 5 cartons delivered in a specific identified batch with quarantined... |
SUBJECT: Dual product inquiry and report about Product A and institutional contract enquiry
BODY:
Dear Pharmacovigilance and Quality Officer,
I am the clinical pharmacy specialist in a busy emergency department and I am contacting you regarding two separate topics. The first is a product defect report for Product A wh... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "92%"}, "Analysis": "The email reports a product quality defect in Product A where the solution appeared cloudy with visible particulate matter that was not described in the product leaflet in a specific identified bat... |
SUBJECT: Observation during use of Product A and Product B
BODY:
Dear Medical Director,
I am the business development lead at MedCore Partners exploring joint procurement initiatives for Product A in nephrology and Product B in hepatology. and I am writing to report two separate issues. The first involves Product A wh... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "91%"}, "Analysis": "The email reports adverse symptoms where the subject had a generalized tonic-clonic seizure approximately 12 hours after the evening dose temporally associated with Product A initiation, wi... |
SUBJECT: Co-therapy observation and commercial query on Product A and supply inquiry
BODY:
Dear Clinical and Supply Chain Team,
I am the head of formulary and medicines optimisation for an integrated care board and I wish to bring two matters to your attention. The first is an adverse reaction report concerning Produc... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the patient experienced a sharp drop in platelet count observed on day 7 lab work temporally associated with Product A initiation, with clinical intervention ta... |
SUBJECT: Comprehensive inquiry on Product A and supply inquiry
BODY:
Dear Drug Safety and Medical Information,
As the formulary coordinator for a 300-bed community hospital and I have two distinct issues to address. The first concerns Product A where The patient is a 33 year old female with multiple sclerosis on immun... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the patient had an episode of syncope approximately 6 hours post-dose temporally associated with Product A initiation, with clinical intervention taken, qualify... |
SUBJECT: Multi-faceted concern about Product A and Product B
BODY:
Dear Post-Market Surveillance,
I am the chief of medicine at a downtown clinic where Product A is prescribed for autoimmune conditions and Product B for metabolic syndrome management. and I am contacting you about two separate matters. The first is a r... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Can you clarify whether Product A i... |
SUBJECT: Labeling error and clinical query about Product A and Product B
BODY:
Dear Medical and Commercial Teams,
I am the healthcare administrator at Premier Medical Group overseeing the concurrent use of Product A in infusion centres and Product B in outpatient pharmacies. and I am writing to formally raise two matt... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the mechanism of action for ... |
SUBJECT: Multi-product safety and information request for Product A and institutional contract enquiry
BODY:
Dear Pharmacy Director,
I am the pharmacy and therapeutics committee chair at a regional medical centre and I wish to bring two matters to your attention. The first is a quality assurance concern with Product A... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "95%"}, "Analysis": "The email reports a product quality defect in Product A where the cap of the dropper bottle was cross-threaded and could not be sealed tightly after opening in a specific identified batch with quar... |
SUBJECT: Distribution and side-effect profile of Product A and institutional contract enquiry
BODY:
Dear Quality Officer,
I am the prescribing advisor for a mental health trust and I am contacting you regarding two separate topics. The first is a product defect report for Product A where the outer box was water-damage... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports a product quality defect in Product A where the outer box was water-damaged during transit, affecting the legibility of dosage instructions printed on the flap in a specific ident... |
SUBJECT: Market access and patient impact of Product A and institutional contract enquiry
BODY:
Dear Clinical Lead Pharmacist,
I am the clinical lead pharmacist at a large teaching hospital and I am contacting you regarding two separate topics. The first is a product defect report for Product A where the syringe plung... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "98%"}, "Analysis": "The email reports a product quality defect in Product A where the syringe plunger was stuck and could not be depressed smoothly, suggesting a manufacturing defect in a specific identified batch wit... |
SUBJECT: Patient feedback concerning Product A and supply inquiry
BODY:
Dear Customer Support,
I am the director of pharmacy for a network of community hospitals and I am writing to formally report two issues. The first is a subject safety concern with Product A where The patient is a 29 year old male with a history o... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the subject noticed significant peripheral edema in both lower limbs after 1 week of use temporally associated with Product A initiation, with clinical interven... |
SUBJECT: Inquiry and feedback about Product A and Product B
BODY:
Dear Clinical Coordinator,
I am the chief pharmacist at a district general hospital where Product A is stocked in critical care and Product B is used in the renal unit. and I need to address two issues simultaneously. The first is a medical information ... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Is Product A approved for pediatric... |
SUBJECT: Observation during use of Product A and Product B
BODY:
Dear Drug Safety Department,
I am the healthcare administrator at Premier Medical Group overseeing the concurrent use of Product A in infusion centres and Product B in outpatient pharmacies. and I wish to raise two issues simultaneously. The first is an ... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient showed signs of acute renal dysfunction with rising creatinine after 5 days temporally associated with Product A initiation, with clinic... |
SUBJECT: Request for details about Product A and institutional contract enquiry
BODY:
Dear Medical Affairs,
I am writing as the clinical coordinator for a multi-site renal network and I wish to bring two matters to your attention. The first is a quality assurance concern with Product A 20mg where a tablet was observed... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports a product quality defect in Product A where a tablet was observed to be split into 2 unequal fragments inside an intact blister cavity in a specific identified batch with quaranti... |
SUBJECT: Integrated feedback regarding Product A and Product B
BODY:
Dear Integrated Quality and Safety Team,
I am the lead clinical coordinator for a hospice network where Product A is used for chronic pain and Product B for breakthrough symptom control. I have two separate concerns to raise. The first is a clinical ... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What are the documented drug-drug i... |
SUBJECT: Complex issue involving Product A and Product B
BODY:
Dear Pharmacy Director,
I am the clinical pharmacy specialist in a busy emergency department where Product A is used for rapid anticoagulation reversal and Product B for gastric acid suppression. and I am formally reporting two concerns. The first is a saf... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "92%"}, "Analysis": "The email reports adverse symptoms where the patient had an episode of syncope approximately 6 hours post-dose temporally associated with Product A initiation, with clinical intervention an... |
SUBJECT: Issue reported with Product A and Product B
BODY:
Dear Integrated Quality and Safety Team,
I am the prescribing advisor for a mental health trust where Product A is used for bipolar disorder and Product B for sleep disturbances. and I am writing to formally raise two matters. The first issues Product A and sp... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there any guidance on dose modifi... |
SUBJECT: Labeling error and clinical query about Product A and supply inquiry
BODY:
Dear Quality Assurance Team,
I am the medical director of a specialist cardiovascular centre and I wish to bring two matters to your attention. The first is an adverse reaction report concerning Product A where The patient is a 73 year... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the patient developed severe photosensitivity with blistering after 14 days of continuous use temporally associated with Product A initiation, with clinical int... |
SUBJECT: Dual product inquiry and report about Product A and Product B
BODY:
Dear Quality Assurance and Commercial Teams,
I am writing as the clinical pharmacist for a long-term care facility where residents receive Product A for chronic heart failure and Product B for osteoporosis prevention. and I wish to raise two ... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "94%"}, "Analysis": "The email reports adverse symptoms where the subject developed Stevens-Johnson syndrome-like lesions across torso and arms temporally associated with Product A initiation, with clinical int... |
SUBJECT: Unexpected reaction linked to Product A and institutional contract enquiry
BODY:
Dear Quality Officer,
As the head of pharmacy procurement for a regional health trust and I wish to bring two matters to your attention. The first is a quality assurance concern with Product A 25mg where the bottle seal was broke... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "92%"}, "Analysis": "The email reports a product quality defect in Product A where the bottle seal was broken upon receipt and 3 tablets were missing from the blister pack in a specific identified batch with quarantine... |
SUBJECT: Multi-product safety and information request for Product A and institutional contract enquiry
BODY:
Dear Clinical Lead Pharmacist,
I am the lead clinical coordinator for a hospice network and I wish to bring two matters to your attention. The first is a quality assurance concern with Product A 20mg where the ... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "93%"}, "Analysis": "The email reports a product quality defect in Product A where the ointment tube was severely swollen, suggesting a reaction between the product and the tube lining in a specific identified batch wi... |
SUBJECT: Integrated feedback regarding Product A and institutional inquiry
BODY:
Dear Pharmacovigilance and Quality Officer,
I am the medical director of a specialist cardiovascular centre and I wish to bring two matters to your attention. The first is a medical information request about Product A specifically Could y... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you send any recent peer-reviewed publ... |
SUBJECT: Comprehensive inquiry on Product A and institutional contract enquiry
BODY:
Dear Adverse Event Reporting Center,
I am the chief pharmacist at a district general hospital and I am writing to formally report two issues. The first is a product complaint regarding Product A where our inspection revealed that the ... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "92%"}, "Analysis": "The email reports a product quality defect in Product A where the expiration date printed on the bottle was smudged and partially illegible in a specific identified batch with quarantined stock and... |
SUBJECT: Observation during use of Product A and Product B
BODY:
Dear Medical and Commercial Teams,
I am writing as the clinical pharmacist for a long-term care facility where residents receive Product A for chronic heart failure and Product B for osteoporosis prevention. and I need to address two separate issues. Reg... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you provide the maximum recomm... |
SUBJECT: Unexpected reaction linked to Product A and institutional inquiry
BODY:
Dear Clinical Affairs,
I am the director of pharmacy for a network of community hospitals and I wish to bring two matters to your attention. The first is a medical information request about Product A specifically Is there any real-world e... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there any real-world evidence on the long... |
SUBJECT: Supply and experience review of Product A and supply inquiry
BODY:
Dear Clinical Lead Pharmacist,
I am the quality officer at a private hospital and I have two distinct issues to address. The first concerns Product A where The subject is a 39 year old female with fibromyalgia and chronic fatigue syndrome. She... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the patient experienced hypoglycemic episodes requiring emergency glucose administration temporally associated with Product A initiation, with clinical interven... |
SUBJECT: Request for details about Product A and Product B
BODY:
Dear Compliance Team,
I am the lead clinical coordinator for a hospice network where Product A is used for chronic pain and Product B for breakthrough symptom control. and I am contacting you about two separate matters. The first is a request for clinica... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Can you provide the pharmacokinetic... |
SUBJECT: Unexpected reaction linked to Product A and supply inquiry
BODY:
Dear Clinical and Supply Chain Team,
I am the ward manager on a busy medical unit and I wish to bring two matters to your attention. The first is an adverse reaction report concerning Product A where The patient is a 60 year old male with hyperl... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient developed bilateral hearing loss and persistent tinnitus after 11 days temporally associated with Product A initiation, with clinical intervention t... |
SUBJECT: Product quality and adverse experience with Product A and Product B
BODY:
Dear Pharmacy Director,
As the medical liaison for Northshore Physicians Group, I coordinate care transitions involving Product A for respiratory conditions and Product B for cardiovascular protection. and I need to bring two matters to... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the patient reported dizziness and orthostatic hypotension after 2 doses temporally associated with Product A initiation, with clinical intervention... |
SUBJECT: Joint product evaluation and safety report for Product A and institutional inquiry
BODY:
Dear Integrated Quality and Safety Team,
I am the clinical lead pharmacist at a large teaching hospital and I wish to bring two matters to your attention. The first is a medical information request about Product A specifi... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the established dosing interval for ... |
SUBJECT: Request for details about Product A and Product B
BODY:
Dear Pharmacy Director,
I am writing as the clinical pharmacist for a long-term care facility where residents receive Product A for chronic heart failure and Product B for osteoporosis prevention. and I need to bring two matters to your attention. Regard... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the patient developed bilateral hearing loss and persistent tinnitus after 11 days temporally associated with Product A initiation, with clinical in... |
SUBJECT: Dual product inquiry and report about Product A and Product B
BODY:
Dear Drug Safety Department,
Our urgent care centre frequently dispenses Product A for acute migraine and Product B for nausea management in the same patient episodes. and I am formally reporting two concerns. The first is a safety issue with... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "92%"}, "Analysis": "The email reports adverse symptoms where the patient reported dizziness and orthostatic hypotension after 2 doses temporally associated with Product A initiation, with clinical intervention... |
SUBJECT: Administrative and medical query on Product A and institutional contract enquiry
BODY:
Dear Quality Officer,
As the pharmacy director of a 500-bed tertiary hospital and I wish to bring two matters to your attention. The first is a quality assurance concern with Product A 100mg where the powder for reconstitut... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports a product quality defect in Product A where the powder for reconstitution formed clumps that did not dissolve completely after 5 minutes of shaking in a specific identified batch ... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.